Colleen Julian
Concepts (392)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Altitude | 56 | 2025 | 482 | 10.640 |
Why?
| | Pre-Eclampsia | 14 | 2024 | 189 | 4.030 |
Why?
| | Fetal Growth Retardation | 24 | 2025 | 565 | 4.030 |
Why?
| | AMP-Activated Protein Kinases | 9 | 2025 | 197 | 3.560 |
Why?
| | Placenta | 12 | 2025 | 747 | 3.520 |
Why?
| | Uterine Artery | 15 | 2024 | 79 | 3.050 |
Why?
| | Hypoxia | 27 | 2024 | 1107 | 3.020 |
Why?
| | Adaptation, Physiological | 13 | 2025 | 546 | 2.650 |
Why?
| | Fetal Hypoxia | 8 | 2024 | 54 | 2.580 |
Why?
| | Pregnancy | 62 | 2025 | 6731 | 2.450 |
Why?
| | Altitude Sickness | 15 | 2022 | 152 | 2.360 |
Why?
| | Fetal Development | 9 | 2025 | 296 | 2.140 |
Why?
| | Placental Circulation | 9 | 2025 | 70 | 1.930 |
Why?
| | Acclimatization | 13 | 2019 | 176 | 1.810 |
Why?
| | Oxygen | 17 | 2025 | 933 | 1.590 |
Why?
| | PPAR gamma | 3 | 2020 | 182 | 1.560 |
Why?
| | Birth Weight | 13 | 2024 | 514 | 1.500 |
Why?
| | Bolivia | 18 | 2025 | 65 | 1.410 |
Why?
| | Vascular Endothelial Growth Factor Receptor-1 | 3 | 2022 | 71 | 0.980 |
Why?
| | Pregnancy Outcome | 4 | 2019 | 409 | 0.970 |
Why?
| | Selection, Genetic | 7 | 2019 | 262 | 0.960 |
Why?
| | Hypertension, Pregnancy-Induced | 5 | 2023 | 68 | 0.960 |
Why?
| | Pregnancy Complications | 5 | 2017 | 522 | 0.930 |
Why?
| | Hemodynamics | 4 | 2024 | 1110 | 0.900 |
Why?
| | Female | 78 | 2025 | 72840 | 0.870 |
Why?
| | Endothelin-1 | 2 | 2020 | 181 | 0.840 |
Why?
| | Biology | 1 | 2023 | 87 | 0.780 |
Why?
| | Hypertension, Pulmonary | 3 | 2025 | 1902 | 0.760 |
Why?
| | Uterus | 4 | 2020 | 215 | 0.750 |
Why?
| | Infant, Newborn | 16 | 2025 | 6046 | 0.730 |
Why?
| | Gestational Age | 12 | 2024 | 902 | 0.670 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2021 | 125 | 0.660 |
Why?
| | Sympathetic Nervous System | 6 | 2020 | 181 | 0.660 |
Why?
| | Regional Blood Flow | 8 | 2024 | 474 | 0.650 |
Why?
| | Humans | 84 | 2025 | 136783 | 0.640 |
Why?
| | Neovascularization, Physiologic | 1 | 2021 | 177 | 0.630 |
Why?
| | Polycythemia | 3 | 2017 | 21 | 0.610 |
Why?
| | Adult | 47 | 2025 | 37616 | 0.590 |
Why?
| | Erythropoietin | 3 | 2017 | 95 | 0.570 |
Why?
| | Pulmonary Circulation | 2 | 2021 | 430 | 0.560 |
Why?
| | Heart Defects, Congenital | 1 | 2025 | 831 | 0.540 |
Why?
| | Vascular Diseases | 2 | 2017 | 244 | 0.530 |
Why?
| | Signal Transduction | 5 | 2025 | 5065 | 0.530 |
Why?
| | Receptors, Erythropoietin | 1 | 2017 | 20 | 0.530 |
Why?
| | Epigenesis, Genetic | 3 | 2023 | 658 | 0.510 |
Why?
| | Infant, Small for Gestational Age | 3 | 2011 | 91 | 0.490 |
Why?
| | Fetus | 5 | 2025 | 806 | 0.480 |
Why?
| | Case-Control Studies | 9 | 2024 | 3537 | 0.480 |
Why?
| | Gene Expression Regulation | 3 | 2021 | 2603 | 0.470 |
Why?
| | Vascular Endothelial Growth Factor A | 3 | 2023 | 544 | 0.470 |
Why?
| | Enzymes | 2 | 2013 | 67 | 0.460 |
Why?
| | Arteries | 3 | 2022 | 268 | 0.450 |
Why?
| | Vasodilation | 4 | 2022 | 495 | 0.440 |
Why?
| | Young Adult | 20 | 2024 | 13126 | 0.430 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2021 | 607 | 0.410 |
Why?
| | Sleep Apnea Syndromes | 1 | 2013 | 89 | 0.380 |
Why?
| | DNA Methylation | 2 | 2023 | 644 | 0.370 |
Why?
| | Blood Proteins | 1 | 2013 | 249 | 0.370 |
Why?
| | Vascular Resistance | 5 | 2024 | 372 | 0.370 |
Why?
| | Antioxidants | 2 | 2013 | 578 | 0.360 |
Why?
| | Hemoglobins | 7 | 2017 | 353 | 0.360 |
Why?
| | Middle Cerebral Artery | 3 | 2024 | 53 | 0.360 |
Why?
| | Infant, Low Birth Weight | 2 | 2011 | 141 | 0.360 |
Why?
| | Cell Membrane Permeability | 1 | 2011 | 80 | 0.360 |
Why?
| | Oxygen Consumption | 2 | 2011 | 696 | 0.350 |
Why?
| | Erythrocytes | 4 | 2017 | 692 | 0.350 |
Why?
| | Placental Insufficiency | 2 | 2023 | 116 | 0.330 |
Why?
| | Biological Evolution | 2 | 2015 | 464 | 0.330 |
Why?
| | Erythropoiesis | 2 | 2014 | 54 | 0.320 |
Why?
| | Oxidative Stress | 2 | 2013 | 1309 | 0.320 |
Why?
| | Cerebrovascular Circulation | 4 | 2024 | 240 | 0.310 |
Why?
| | Polymorphism, Single Nucleotide | 8 | 2019 | 2190 | 0.310 |
Why?
| | Lung Diseases | 1 | 2015 | 768 | 0.300 |
Why?
| | Fertility | 1 | 2009 | 159 | 0.290 |
Why?
| | Women's Health | 1 | 2011 | 369 | 0.290 |
Why?
| | Lung | 1 | 2021 | 4065 | 0.280 |
Why?
| | Animals | 14 | 2025 | 36768 | 0.280 |
Why?
| | Proteomics | 1 | 2013 | 1108 | 0.260 |
Why?
| | Receptor, Adenosine A2B | 2 | 2017 | 43 | 0.260 |
Why?
| | Hypertension | 1 | 2015 | 1284 | 0.260 |
Why?
| | Maternal-Fetal Exchange | 2 | 2021 | 165 | 0.250 |
Why?
| | Disease Models, Animal | 3 | 2021 | 4279 | 0.240 |
Why?
| | Nitric Oxide | 2 | 2020 | 914 | 0.230 |
Why?
| | Male | 21 | 2025 | 67361 | 0.230 |
Why?
| | Cardiovascular Physiological Phenomena | 1 | 2024 | 42 | 0.220 |
Why?
| | Infant Mortality | 1 | 2025 | 115 | 0.220 |
Why?
| | Placenta Growth Factor | 2 | 2022 | 24 | 0.210 |
Why?
| | HELLP Syndrome | 1 | 2023 | 6 | 0.210 |
Why?
| | Physical Education and Training | 1 | 2003 | 76 | 0.210 |
Why?
| | Blood Pressure | 7 | 2020 | 1772 | 0.210 |
Why?
| | Neonatal Screening | 1 | 2025 | 169 | 0.210 |
Why?
| | Phenylephrine | 2 | 2020 | 75 | 0.200 |
Why?
| | Glucose | 2 | 2025 | 1019 | 0.200 |
Why?
| | Europe | 5 | 2019 | 414 | 0.200 |
Why?
| | Ion Channels | 1 | 2023 | 132 | 0.200 |
Why?
| | Mice, Inbred C57BL | 5 | 2021 | 5744 | 0.200 |
Why?
| | Muscle, Skeletal | 5 | 2023 | 1707 | 0.200 |
Why?
| | Amino Acids | 3 | 2023 | 500 | 0.200 |
Why?
| | Baroreflex | 3 | 2020 | 57 | 0.200 |
Why?
| | Task Performance and Analysis | 1 | 2003 | 183 | 0.200 |
Why?
| | Geography | 3 | 2011 | 197 | 0.190 |
Why?
| | Phenotype | 2 | 2023 | 3199 | 0.190 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 2022 | 79 | 0.190 |
Why?
| | Mice | 7 | 2021 | 17731 | 0.190 |
Why?
| | Cesarean Section | 1 | 2023 | 185 | 0.190 |
Why?
| | Longitudinal Studies | 3 | 2019 | 2847 | 0.190 |
Why?
| | Acute Disease | 3 | 2013 | 1006 | 0.180 |
Why?
| | Acetazolamide | 2 | 2011 | 26 | 0.180 |
Why?
| | Arterial Pressure | 3 | 2020 | 125 | 0.180 |
Why?
| | Abortion, Spontaneous | 2 | 2020 | 105 | 0.180 |
Why?
| | Postpartum Period | 1 | 2024 | 336 | 0.180 |
Why?
| | Running | 1 | 2003 | 230 | 0.180 |
Why?
| | Ventricular Pressure | 1 | 2021 | 48 | 0.180 |
Why?
| | Pedigree | 2 | 2020 | 514 | 0.170 |
Why?
| | Hyperbaric Oxygenation | 1 | 2021 | 39 | 0.170 |
Why?
| | Phosphorylation | 3 | 2021 | 1756 | 0.170 |
Why?
| | Cardiovascular System | 2 | 2024 | 139 | 0.170 |
Why?
| | Cross-Sectional Studies | 4 | 2022 | 5417 | 0.170 |
Why?
| | Mammals | 1 | 2022 | 283 | 0.170 |
Why?
| | Biomarkers | 4 | 2017 | 4158 | 0.170 |
Why?
| | Frailty | 1 | 2023 | 170 | 0.170 |
Why?
| | Blood Volume | 3 | 2017 | 61 | 0.170 |
Why?
| | Prevalence | 2 | 2025 | 2712 | 0.170 |
Why?
| | Pregnancy-Associated Plasma Protein-A | 1 | 2020 | 14 | 0.170 |
Why?
| | Inflammation | 1 | 2011 | 2834 | 0.160 |
Why?
| | Myometrium | 1 | 2020 | 39 | 0.160 |
Why?
| | Geographic Mapping | 1 | 2019 | 23 | 0.160 |
Why?
| | Genomics | 2 | 2023 | 790 | 0.160 |
Why?
| | Pulmonary Artery | 2 | 2015 | 1082 | 0.160 |
Why?
| | Hypoxia-Inducible Factor-Proline Dioxygenases | 2 | 2017 | 21 | 0.160 |
Why?
| | Thiazolidinediones | 1 | 2020 | 137 | 0.150 |
Why?
| | Genetics, Population | 2 | 2010 | 210 | 0.150 |
Why?
| | Dexamethasone | 2 | 2011 | 377 | 0.150 |
Why?
| | Nitric Oxide Synthase | 1 | 2019 | 240 | 0.150 |
Why?
| | Ventricular Function, Right | 1 | 2021 | 283 | 0.150 |
Why?
| | Adenosine | 2 | 2017 | 226 | 0.150 |
Why?
| | Gene Expression | 1 | 2023 | 1499 | 0.140 |
Why?
| | Protein Kinases | 1 | 2020 | 319 | 0.140 |
Why?
| | Peroneal Nerve | 1 | 2017 | 19 | 0.140 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2021 | 429 | 0.140 |
Why?
| | Puberty | 1 | 2019 | 146 | 0.140 |
Why?
| | Trophoblasts | 1 | 2019 | 199 | 0.140 |
Why?
| | Maternal Health Services | 1 | 2019 | 97 | 0.140 |
Why?
| | Time Factors | 5 | 2017 | 6792 | 0.140 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 2 | 2017 | 241 | 0.140 |
Why?
| | Equilibrative Nucleoside Transporter 1 | 1 | 2017 | 17 | 0.130 |
Why?
| | Insulin Resistance | 1 | 2025 | 1201 | 0.130 |
Why?
| | Epigenomics | 1 | 2017 | 115 | 0.130 |
Why?
| | Cell Cycle Proteins | 1 | 2021 | 611 | 0.130 |
Why?
| | Body Mass Index | 1 | 2025 | 2364 | 0.130 |
Why?
| | Heart Rate | 5 | 2020 | 823 | 0.130 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2019 | 444 | 0.130 |
Why?
| | Colorado | 3 | 2019 | 4491 | 0.130 |
Why?
| | Sphingosine | 1 | 2016 | 46 | 0.130 |
Why?
| | Lysophospholipids | 1 | 2016 | 80 | 0.120 |
Why?
| | Autonomic Pathways | 1 | 2015 | 2 | 0.120 |
Why?
| | Immunohistochemistry | 1 | 2020 | 1731 | 0.120 |
Why?
| | Blood Glucose | 1 | 2025 | 2180 | 0.120 |
Why?
| | California | 1 | 2017 | 424 | 0.120 |
Why?
| | Pregnancy Complications, Cardiovascular | 2 | 2024 | 77 | 0.120 |
Why?
| | Pulmonary Gas Exchange | 1 | 2015 | 121 | 0.120 |
Why?
| | Double-Blind Method | 3 | 2011 | 1981 | 0.120 |
Why?
| | Pulmonary Veins | 1 | 2015 | 99 | 0.110 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 849 | 0.110 |
Why?
| | Muscles | 1 | 2015 | 325 | 0.110 |
Why?
| | Receptor, Endothelin A | 1 | 2014 | 64 | 0.110 |
Why?
| | Diabetes, Gestational | 1 | 2018 | 316 | 0.110 |
Why?
| | Aromatase | 1 | 2014 | 32 | 0.110 |
Why?
| | Ultrasonography, Prenatal | 4 | 2024 | 284 | 0.110 |
Why?
| | Biological Transport | 2 | 2019 | 411 | 0.110 |
Why?
| | Parity | 3 | 2018 | 126 | 0.110 |
Why?
| | Homeostasis | 2 | 2014 | 618 | 0.100 |
Why?
| | Adolescent Behavior | 1 | 2019 | 534 | 0.100 |
Why?
| | Incidence | 2 | 2018 | 2788 | 0.100 |
Why?
| | Tibet | 4 | 2017 | 27 | 0.100 |
Why?
| | Congenital Abnormalities | 2 | 1991 | 88 | 0.100 |
Why?
| | Prospective Studies | 3 | 2022 | 7583 | 0.100 |
Why?
| | Ultrasonography, Doppler | 3 | 2020 | 123 | 0.100 |
Why?
| | Leukocytes, Mononuclear | 1 | 2015 | 556 | 0.100 |
Why?
| | Endothelium, Vascular | 1 | 2019 | 925 | 0.100 |
Why?
| | Body Height | 1 | 2013 | 199 | 0.100 |
Why?
| | Delivery, Obstetric | 2 | 2011 | 145 | 0.100 |
Why?
| | Regression Analysis | 3 | 2018 | 1024 | 0.100 |
Why?
| | Glycolysis | 3 | 2021 | 318 | 0.100 |
Why?
| | Healthy Volunteers | 3 | 2017 | 197 | 0.090 |
Why?
| | Polysomnography | 1 | 2013 | 185 | 0.090 |
Why?
| | Prenatal Diagnosis | 2 | 1991 | 202 | 0.090 |
Why?
| | Carbonic Anhydrase Inhibitors | 1 | 2011 | 14 | 0.090 |
Why?
| | Apgar Score | 1 | 2011 | 17 | 0.090 |
Why?
| | Risk Factors | 6 | 2019 | 10331 | 0.090 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2013 | 591 | 0.090 |
Why?
| | Exercise | 2 | 2023 | 2038 | 0.090 |
Why?
| | Health Services Accessibility | 1 | 2019 | 976 | 0.090 |
Why?
| | Hypoxia, Brain | 1 | 2011 | 8 | 0.090 |
Why?
| | Mountaineering | 1 | 2011 | 40 | 0.090 |
Why?
| | Respiratory Physiological Phenomena | 1 | 2011 | 31 | 0.090 |
Why?
| | Estrogens | 1 | 2014 | 367 | 0.090 |
Why?
| | Brain Edema | 1 | 2011 | 61 | 0.090 |
Why?
| | Respiratory Function Tests | 1 | 2013 | 596 | 0.090 |
Why?
| | Angiostatic Proteins | 1 | 2010 | 5 | 0.090 |
Why?
| | Lactic Acid | 2 | 2023 | 306 | 0.090 |
Why?
| | Angiogenic Proteins | 1 | 2010 | 16 | 0.090 |
Why?
| | Tandem Mass Spectrometry | 1 | 2013 | 532 | 0.080 |
Why?
| | Confidence Intervals | 1 | 2011 | 328 | 0.080 |
Why?
| | Follow-Up Studies | 2 | 2017 | 5115 | 0.080 |
Why?
| | Headache | 1 | 2011 | 151 | 0.080 |
Why?
| | Blood-Brain Barrier | 1 | 2011 | 140 | 0.080 |
Why?
| | Oxidation-Reduction | 1 | 2013 | 1062 | 0.080 |
Why?
| | Anthropology, Physical | 1 | 2009 | 28 | 0.080 |
Why?
| | Sheep | 2 | 2023 | 855 | 0.080 |
Why?
| | Retrospective Studies | 4 | 2022 | 15564 | 0.080 |
Why?
| | Databases, Genetic | 1 | 2010 | 236 | 0.080 |
Why?
| | Fetal Diseases | 1 | 1991 | 173 | 0.080 |
Why?
| | Adolescent | 4 | 2019 | 21463 | 0.080 |
Why?
| | Cohort Studies | 3 | 2020 | 5718 | 0.080 |
Why?
| | HIV Infections | 1 | 2023 | 2812 | 0.080 |
Why?
| | Up-Regulation | 1 | 2011 | 843 | 0.070 |
Why?
| | Fetal Blood | 1 | 2011 | 327 | 0.070 |
Why?
| | Age Factors | 2 | 2019 | 3290 | 0.070 |
Why?
| | South America | 3 | 2014 | 59 | 0.070 |
Why?
| | Interleukin-1beta | 1 | 2010 | 372 | 0.070 |
Why?
| | Prognosis | 1 | 2017 | 4018 | 0.070 |
Why?
| | Genome, Human | 1 | 2010 | 424 | 0.070 |
Why?
| | Chronic Disease | 1 | 2013 | 1784 | 0.070 |
Why?
| | Anti-Inflammatory Agents | 1 | 2011 | 495 | 0.070 |
Why?
| | Head | 1 | 2008 | 105 | 0.070 |
Why?
| | Rest | 2 | 2019 | 121 | 0.070 |
Why?
| | Urban Health | 1 | 2007 | 92 | 0.070 |
Why?
| | 5'-Nucleotidase | 2 | 2017 | 41 | 0.070 |
Why?
| | 2,3-Diphosphoglycerate | 2 | 2016 | 32 | 0.060 |
Why?
| | GPI-Linked Proteins | 2 | 2017 | 70 | 0.060 |
Why?
| | Indians, South American | 3 | 2013 | 25 | 0.060 |
Why?
| | Health Status | 1 | 2011 | 781 | 0.060 |
Why?
| | Femur | 1 | 2008 | 256 | 0.060 |
Why?
| | Blood Flow Velocity | 3 | 2013 | 412 | 0.060 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2007 | 106 | 0.060 |
Why?
| | Haplotypes | 2 | 2017 | 490 | 0.060 |
Why?
| | Cold Temperature | 2 | 2017 | 177 | 0.060 |
Why?
| | Maternal Age | 2 | 2018 | 129 | 0.060 |
Why?
| | Mental Health | 1 | 2011 | 721 | 0.060 |
Why?
| | Umbilical Arteries | 1 | 2024 | 54 | 0.060 |
Why?
| | Reticulocyte Count | 1 | 2003 | 6 | 0.050 |
Why?
| | Down Syndrome | 1 | 1991 | 490 | 0.050 |
Why?
| | Receptors, Transferrin | 1 | 2003 | 24 | 0.050 |
Why?
| | Chi-Square Distribution | 2 | 2018 | 532 | 0.050 |
Why?
| | Indians, North American | 1 | 2009 | 625 | 0.050 |
Why?
| | Pyruvates | 1 | 2023 | 24 | 0.050 |
Why?
| | Solubility | 1 | 2003 | 247 | 0.050 |
Why?
| | Gene Expression Profiling | 1 | 2010 | 1768 | 0.050 |
Why?
| | Surveys and Questionnaires | 3 | 2013 | 5749 | 0.050 |
Why?
| | Glutamine | 1 | 2023 | 104 | 0.050 |
Why?
| | Serine | 1 | 2023 | 141 | 0.050 |
Why?
| | Body Weight | 1 | 2007 | 981 | 0.050 |
Why?
| | Cytokines | 1 | 2010 | 2088 | 0.050 |
Why?
| | Glycine | 1 | 2023 | 175 | 0.050 |
Why?
| | Potassium Channels | 1 | 2022 | 150 | 0.050 |
Why?
| | Gene Frequency | 2 | 2014 | 520 | 0.050 |
Why?
| | Pyruvic Acid | 1 | 2021 | 54 | 0.050 |
Why?
| | Developing Countries | 1 | 2023 | 306 | 0.040 |
Why?
| | Blood Gas Analysis | 2 | 2014 | 74 | 0.040 |
Why?
| | Amniocentesis | 2 | 1991 | 25 | 0.040 |
Why?
| | Pyrones | 1 | 2020 | 9 | 0.040 |
Why?
| | Aminoimidazole Carboxamide | 1 | 2020 | 12 | 0.040 |
Why?
| | Pregnancy Trimester, Third | 2 | 2019 | 114 | 0.040 |
Why?
| | Ribonucleotides | 1 | 2020 | 26 | 0.040 |
Why?
| | Adenosine Triphosphate | 1 | 2022 | 486 | 0.040 |
Why?
| | Biphenyl Compounds | 1 | 2020 | 63 | 0.040 |
Why?
| | Thiophenes | 1 | 2020 | 118 | 0.040 |
Why?
| | Mice, Knockout | 2 | 2017 | 2999 | 0.040 |
Why?
| | Acetylcholine | 1 | 2020 | 186 | 0.040 |
Why?
| | Vasoconstrictor Agents | 1 | 2020 | 138 | 0.040 |
Why?
| | Accelerometry | 1 | 2019 | 98 | 0.040 |
Why?
| | Vasodilator Agents | 1 | 2020 | 331 | 0.040 |
Why?
| | Ultrasonography | 2 | 2014 | 751 | 0.030 |
Why?
| | Renin | 1 | 2017 | 34 | 0.030 |
Why?
| | Arginine Vasopressin | 1 | 2017 | 43 | 0.030 |
Why?
| | Evoked Potentials, Motor | 1 | 2017 | 50 | 0.030 |
Why?
| | Aldosterone | 1 | 2017 | 44 | 0.030 |
Why?
| | Genotype | 2 | 2014 | 1919 | 0.030 |
Why?
| | Recruitment, Neurophysiological | 1 | 2017 | 45 | 0.030 |
Why?
| | Genome-Wide Association Study | 2 | 2017 | 1434 | 0.030 |
Why?
| | Osmolar Concentration | 1 | 2017 | 170 | 0.030 |
Why?
| | Ferritins | 1 | 2017 | 64 | 0.030 |
Why?
| | Bisphosphoglycerate Mutase | 1 | 2016 | 7 | 0.030 |
Why?
| | Ubiquitination | 1 | 2017 | 102 | 0.030 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2016 | 16 | 0.030 |
Why?
| | Pentose Phosphate Pathway | 1 | 2016 | 53 | 0.030 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 2016 | 45 | 0.030 |
Why?
| | Sulfur | 1 | 2016 | 58 | 0.030 |
Why?
| | Posture | 1 | 2017 | 186 | 0.030 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2017 | 135 | 0.030 |
Why?
| | Child | 2 | 2019 | 21968 | 0.030 |
Why?
| | Mice, Mutant Strains | 1 | 2016 | 298 | 0.030 |
Why?
| | Purines | 1 | 2016 | 176 | 0.030 |
Why?
| | Gene-Environment Interaction | 1 | 2017 | 194 | 0.030 |
Why?
| | Diastole | 1 | 2015 | 150 | 0.030 |
Why?
| | Arginine | 1 | 2016 | 271 | 0.030 |
Why?
| | Vagus Nerve | 1 | 2015 | 86 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1513 | 0.030 |
Why?
| | Glutathione | 1 | 2016 | 357 | 0.030 |
Why?
| | Insulin | 1 | 2025 | 2399 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2016 | 813 | 0.030 |
Why?
| | Receptor, Endothelin B | 1 | 2014 | 50 | 0.030 |
Why?
| | Receptors, Endothelin | 1 | 2014 | 51 | 0.030 |
Why?
| | Action Potentials | 1 | 2017 | 495 | 0.030 |
Why?
| | Ultrasonography, Doppler, Transcranial | 1 | 2013 | 45 | 0.030 |
Why?
| | Protein Processing, Post-Translational | 1 | 2016 | 467 | 0.030 |
Why?
| | Evaluation Studies as Topic | 2 | 1991 | 177 | 0.030 |
Why?
| | Body Weights and Measures | 1 | 2013 | 36 | 0.030 |
Why?
| | Radial Artery | 1 | 2013 | 68 | 0.030 |
Why?
| | Infant | 2 | 2020 | 9442 | 0.030 |
Why?
| | Acute Lung Injury | 1 | 2016 | 288 | 0.030 |
Why?
| | Aging | 1 | 2023 | 1861 | 0.030 |
Why?
| | Metabolome | 1 | 2016 | 350 | 0.030 |
Why?
| | Sex Factors | 1 | 2019 | 2068 | 0.020 |
Why?
| | Gonadal Steroid Hormones | 1 | 2014 | 140 | 0.020 |
Why?
| | Brain | 1 | 2024 | 2669 | 0.020 |
Why?
| | Genetic Association Studies | 1 | 2014 | 376 | 0.020 |
Why?
| | Obstetric Labor, Premature | 1 | 1992 | 36 | 0.020 |
Why?
| | Gene Regulatory Networks | 1 | 2014 | 308 | 0.020 |
Why?
| | Linear Models | 1 | 2014 | 845 | 0.020 |
Why?
| | Cardiovascular Diseases | 1 | 2024 | 2108 | 0.020 |
Why?
| | Aged | 2 | 2023 | 23729 | 0.020 |
Why?
| | Pregnancy, High-Risk | 1 | 1991 | 14 | 0.020 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2014 | 412 | 0.020 |
Why?
| | Laser-Doppler Flowmetry | 1 | 2011 | 32 | 0.020 |
Why?
| | Globins | 1 | 2010 | 22 | 0.020 |
Why?
| | Exercise Test | 1 | 2014 | 625 | 0.020 |
Why?
| | Live Birth | 1 | 2011 | 65 | 0.020 |
Why?
| | Procollagen-Proline Dioxygenase | 1 | 2010 | 22 | 0.020 |
Why?
| | Iliac Artery | 1 | 2011 | 55 | 0.020 |
Why?
| | Stillbirth | 1 | 2011 | 72 | 0.020 |
Why?
| | Pregnancy Proteins | 1 | 2010 | 36 | 0.020 |
Why?
| | Renin-Angiotensin System | 1 | 2010 | 84 | 0.020 |
Why?
| | Interleukin-4 | 1 | 2010 | 217 | 0.020 |
Why?
| | DNA Copy Number Variations | 1 | 2010 | 182 | 0.020 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2010 | 253 | 0.020 |
Why?
| | Prenatal Care | 1 | 1992 | 287 | 0.020 |
Why?
| | Anticonvulsants | 1 | 2011 | 216 | 0.020 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2010 | 277 | 0.020 |
Why?
| | Intestinal Neoplasms | 1 | 1968 | 29 | 0.020 |
Why?
| | Cross-Over Studies | 1 | 2011 | 560 | 0.020 |
Why?
| | Interleukin-10 | 1 | 2010 | 302 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2011 | 1318 | 0.020 |
Why?
| | Insurance, Health | 1 | 1990 | 278 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2014 | 1453 | 0.020 |
Why?
| | Radiotherapy | 1 | 1968 | 201 | 0.020 |
Why?
| | Heart Rate, Fetal | 1 | 2007 | 21 | 0.020 |
Why?
| | Models, Biological | 1 | 2015 | 1769 | 0.020 |
Why?
| | Infant, Premature | 1 | 1992 | 567 | 0.020 |
Why?
| | Lymphoma | 1 | 1968 | 206 | 0.020 |
Why?
| | Premature Birth | 1 | 2011 | 330 | 0.020 |
Why?
| | Biometry | 1 | 2007 | 70 | 0.020 |
Why?
| | Respiratory Mechanics | 1 | 2007 | 67 | 0.020 |
Why?
| | Lymphoma, Large B-Cell, Diffuse | 1 | 1968 | 124 | 0.020 |
Why?
| | Middle Aged | 2 | 2019 | 33200 | 0.020 |
Why?
| | Carcinoma | 1 | 1968 | 236 | 0.020 |
Why?
| | Phylogeny | 1 | 2010 | 896 | 0.020 |
Why?
| | Patient Selection | 1 | 1990 | 689 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2010 | 778 | 0.020 |
Why?
| | Cognition | 1 | 2014 | 1166 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 1991 | 1942 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2013 | 2831 | 0.020 |
Why?
| | Uterine Cervical Neoplasms | 1 | 1968 | 254 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2017 | 7569 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2010 | 1242 | 0.010 |
Why?
| | Heart Failure | 1 | 2017 | 2228 | 0.010 |
Why?
| | Patient Acceptance of Health Care | 1 | 1990 | 806 | 0.010 |
Why?
| | Lower Extremity | 1 | 2007 | 424 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2010 | 2417 | 0.010 |
Why?
| | France | 2 | 1992 | 33 | 0.010 |
Why?
| | Risk Assessment | 1 | 2010 | 3429 | 0.010 |
Why?
| | Educational Status | 2 | 1992 | 482 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2011 | 10764 | 0.010 |
Why?
| | Hospitals, Maternity | 1 | 1992 | 4 | 0.010 |
Why?
| | Fathers | 1 | 1992 | 50 | 0.010 |
Why?
| | Marriage | 1 | 1992 | 121 | 0.010 |
Why?
| | Occupations | 1 | 1990 | 48 | 0.010 |
Why?
| | Social Values | 1 | 1990 | 36 | 0.010 |
Why?
| | Chromosome Disorders | 1 | 1990 | 43 | 0.010 |
Why?
| | Personal Autonomy | 1 | 1990 | 47 | 0.010 |
Why?
| | Resource Allocation | 1 | 1990 | 51 | 0.010 |
Why?
| | Religion | 1 | 1990 | 70 | 0.000 |
Why?
| | Chromosome Aberrations | 1 | 1990 | 155 | 0.000 |
Why?
| | Culture | 1 | 1990 | 127 | 0.000 |
Why?
| | Estriol | 1 | 1968 | 8 | 0.000 |
Why?
| | Pregnancy Trimester, Second | 1 | 1989 | 80 | 0.000 |
Why?
| | Chorionic Gonadotropin | 1 | 1968 | 80 | 0.000 |
Why?
| | Ileum | 1 | 1968 | 119 | 0.000 |
Why?
| | Social Class | 1 | 1990 | 277 | 0.000 |
Why?
| | Risk | 1 | 1990 | 904 | 0.000 |
Why?
| | Smoking | 1 | 1992 | 1633 | 0.000 |
Why?
|
|
Julian's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|